nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—Benzphetamine—SLC18A2—Parkinson's disease	0.0148	0.0767	CrCbGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.0105	0.013	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.00963	0.0119	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.0096	0.0119	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00924	0.0114	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR2A—Parkinson's disease	0.00921	0.0114	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00872	0.0108	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.00861	0.0107	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.00858	0.0106	CbGpPWpGaD
Doxylamine—Clemastine—CYP2D6—Parkinson's disease	0.00795	0.0412	CrCbGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00776	0.00962	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.00774	0.00959	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00744	0.00922	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.00742	0.00919	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0073	0.00904	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—GRK5—Parkinson's disease	0.00727	0.00901	CbGpPWpGaD
Doxylamine—Chlorphenamine—SLC6A3—Parkinson's disease	0.00725	0.0376	CrCbGaD
Doxylamine—Mepyramine—CYP2D6—Parkinson's disease	0.00708	0.0367	CrCbGaD
Doxylamine—Tripelennamine—CYP2D6—Parkinson's disease	0.00656	0.034	CrCbGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00653	0.00809	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00651	0.00806	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00638	0.0079	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.00636	0.00787	CbGpPWpGaD
Doxylamine—Benzphetamine—SLC6A3—Parkinson's disease	0.00614	0.0318	CrCbGaD
Doxylamine—Carbinoxamine—CYP2E1—Parkinson's disease	0.0061	0.0316	CrCbGaD
Doxylamine—Atomoxetine—SLC6A3—Parkinson's disease	0.00609	0.0316	CrCbGaD
Doxylamine—Cyclobenzaprine—HTR2A—Parkinson's disease	0.00596	0.0309	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—DDC—Parkinson's disease	0.00565	0.007	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—FGF20—Parkinson's disease	0.00553	0.00685	CbGpPWpGaD
Doxylamine—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.00545	0.0282	CrCbGaD
Doxylamine—Brompheniramine—CYP2E1—Parkinson's disease	0.00529	0.0274	CrCbGaD
Doxylamine—HRH1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00528	0.00654	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—GRM5—Parkinson's disease	0.00526	0.00652	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GPR37—Parkinson's disease	0.00486	0.00602	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GPR37—Parkinson's disease	0.00484	0.006	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00472	0.00585	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.0047	0.00583	CbGpPWpGaD
Doxylamine—Toremifene—ABCB1—Parkinson's disease	0.0045	0.0233	CrCbGaD
Doxylamine—Carbinoxamine—CYP2D6—Parkinson's disease	0.00448	0.0232	CrCbGaD
Doxylamine—Promazine—DRD1—Parkinson's disease	0.00448	0.0232	CrCbGaD
Doxylamine—Imipramine—HTR7—Parkinson's disease	0.00425	0.022	CrCbGaD
Doxylamine—Amitriptyline—HTR7—Parkinson's disease	0.00422	0.0219	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00422	0.00523	CbGpPWpGaD
Doxylamine—Doxepin—HTR1A—Parkinson's disease	0.00418	0.0217	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00411	0.00509	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.0041	0.00507	CbGpPWpGaD
Doxylamine—Amitriptyline—DRD3—Parkinson's disease	0.00397	0.0206	CrCbGaD
Doxylamine—Brompheniramine—CYP2D6—Parkinson's disease	0.00388	0.0201	CrCbGaD
Doxylamine—HRH1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00383	0.00475	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00382	0.00473	CbGpPWpGaD
Doxylamine—Chlorphenamine—CYP2D6—Parkinson's disease	0.00381	0.0198	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00376	0.00466	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00375	0.00464	CbGpPWpGaD
Doxylamine—Imipramine—SLC6A3—Parkinson's disease	0.00372	0.0193	CrCbGaD
Doxylamine—Dextropropoxyphene—CYP2D6—Parkinson's disease	0.00368	0.0191	CrCbGaD
Doxylamine—Doxepin—DRD2—Parkinson's disease	0.00355	0.0184	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD1—Parkinson's disease	0.00354	0.00438	CbGpPWpGaD
Doxylamine—Atomoxetine—HTR2A—Parkinson's disease	0.0035	0.0181	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00347	0.0043	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00346	0.00428	CbGpPWpGaD
Doxylamine—Tamoxifen—CYP2E1—Parkinson's disease	0.00343	0.0178	CrCbGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00343	0.00425	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD3—Parkinson's disease	0.00343	0.00424	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00342	0.00423	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.0034	0.00421	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00339	0.0042	CbGpPWpGaD
Doxylamine—Orphenadrine—CYP2E1—Parkinson's disease	0.00333	0.0173	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—GRM4—Parkinson's disease	0.0033	0.00409	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.00329	0.00408	CbGpPWpGaD
Doxylamine—Imipramine—HTR1A—Parkinson's disease	0.00326	0.0169	CrCbGaD
Doxylamine—Amitriptyline—HTR1A—Parkinson's disease	0.00323	0.0168	CrCbGaD
Doxylamine—Atomoxetine—CYP2D6—Parkinson's disease	0.0032	0.0166	CrCbGaD
Doxylamine—Promazine—DRD2—Parkinson's disease	0.00316	0.0164	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—TH—Parkinson's disease	0.00315	0.00391	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—PENK—Parkinson's disease	0.00313	0.00388	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—PENK—Parkinson's disease	0.00312	0.00386	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD2—Parkinson's disease	0.0031	0.00384	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—HTR7—Parkinson's disease	0.0031	0.00384	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00304	0.00377	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00303	0.00375	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00301	0.00373	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.003	0.00372	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00297	0.00368	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00296	0.00367	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00291	0.0036	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0029	0.00359	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—PDYN—Parkinson's disease	0.00286	0.00355	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.00285	0.00353	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00281	0.00349	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00281	0.00348	CbGpPWpGaD
Doxylamine—Imipramine—DRD2—Parkinson's disease	0.00276	0.0143	CrCbGaD
Doxylamine—Amitriptyline—DRD2—Parkinson's disease	0.00275	0.0142	CrCbGaD
Doxylamine—HRH1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00274	0.0034	CbGpPWpGaD
Doxylamine—Doxepin—HTR2A—Parkinson's disease	0.00274	0.0142	CrCbGaD
Doxylamine—CHRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00274	0.00339	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—GRM5—Parkinson's disease	0.00266	0.0033	CbGpPWpGaD
Doxylamine—Imipramine—CYP2E1—Parkinson's disease	0.00266	0.0138	CrCbGaD
Doxylamine—CHRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00265	0.00329	CbGpPWpGaD
Doxylamine—Amitriptyline—CYP2E1—Parkinson's disease	0.00264	0.0137	CrCbGaD
Doxylamine—HRH1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00264	0.00327	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00263	0.00326	CbGpPWpGaD
Doxylamine—Diphenhydramine—CYP2D6—Parkinson's disease	0.00259	0.0134	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00258	0.00319	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00257	0.00318	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00254	0.00315	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00254	0.00315	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00254	0.00315	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00254	0.00314	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00254	0.00314	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00253	0.00314	CbGpPWpGaD
Doxylamine—Tamoxifen—CYP2D6—Parkinson's disease	0.00252	0.0131	CrCbGaD
Doxylamine—Doxepin—CYP2D6—Parkinson's disease	0.00251	0.013	CrCbGaD
Doxylamine—Methadone—CYP2D6—Parkinson's disease	0.0025	0.0129	CrCbGaD
Doxylamine—HRH1—Signaling by GPCR—GPR37—Parkinson's disease	0.00249	0.00309	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00249	0.00309	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00249	0.00308	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00248	0.00308	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00248	0.00308	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00248	0.00307	CbGpPWpGaD
Doxylamine—Promazine—HTR2A—Parkinson's disease	0.00244	0.0126	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00241	0.00299	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.0024	0.00298	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00236	0.00292	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00235	0.00291	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00231	0.00286	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.0023	0.00285	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00228	0.00282	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00227	0.00281	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00226	0.0028	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00225	0.00279	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00218	0.0027	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00218	0.0027	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00217	0.00269	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00217	0.00269	CbGpPWpGaD
Doxylamine—Imipramine—HTR2A—Parkinson's disease	0.00214	0.0111	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—Parkinson's disease	0.00212	0.011	CrCbGaD
Doxylamine—HRH1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00208	0.00258	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00207	0.00257	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00206	0.00256	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00206	0.00255	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00196	0.00243	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00196	0.00242	CbGpPWpGaD
Doxylamine—Imipramine—CYP2D6—Parkinson's disease	0.00195	0.0101	CrCbGaD
Doxylamine—Amitriptyline—CYP2D6—Parkinson's disease	0.00194	0.0101	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—TAC1—Parkinson's disease	0.00193	0.0024	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00193	0.00239	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD1—Parkinson's disease	0.0019	0.00235	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00189	0.00234	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GRK5—Parkinson's disease	0.00189	0.00234	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00188	0.00233	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00187	0.00231	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00186	0.0023	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD3—Parkinson's disease	0.00184	0.00227	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00183	0.00227	CbGpPWpGaD
Doxylamine—Tamoxifen—ABCB1—Parkinson's disease	0.0018	0.00932	CrCbGaD
Doxylamine—Doxepin—ABCB1—Parkinson's disease	0.00179	0.00929	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00178	0.00221	CbGpPWpGaD
Doxylamine—Methadone—ABCB1—Parkinson's disease	0.00178	0.00924	CrCbGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00178	0.0022	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—VPS35—Parkinson's disease	0.00178	0.0022	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00177	0.00219	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PENK—Parkinson's disease	0.00177	0.00219	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00176	0.00218	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00175	0.00216	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00174	0.00216	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—GRM4—Parkinson's disease	0.00169	0.0021	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00169	0.00209	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR7—Parkinson's disease	0.00166	0.00206	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD2—Parkinson's disease	0.00166	0.00206	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00166	0.00205	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00166	0.00205	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00162	0.002	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00161	0.002	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PENK—Parkinson's disease	0.00161	0.00199	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.0016	0.00198	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00153	0.00189	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00152	0.00189	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0015	0.00186	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0015	0.00186	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GPR37—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DGKQ—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PDYN—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00147	0.00182	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00146	0.00181	CbGpPWpGaD
Doxylamine—Imipramine—ABCB1—Parkinson's disease	0.00139	0.00723	CrCbGaD
Doxylamine—Amitriptyline—ABCB1—Parkinson's disease	0.00139	0.00718	CrCbGaD
Doxylamine—HRH1—Signaling by GPCR—GRM5—Parkinson's disease	0.00137	0.00169	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00136	0.00169	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00135	0.00167	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00134	0.00166	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—EDN1—Parkinson's disease	0.00133	0.00165	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.00133	0.00164	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00128	0.00158	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00127	0.00158	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.00118	0.00146	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RIT2—Parkinson's disease	0.00118	0.00146	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.00117	0.00145	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00116	0.00144	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00116	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00116	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00116	0.00143	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRK5—Parkinson's disease	0.00112	0.00138	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00111	0.00138	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00111	0.00137	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00111	0.00137	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00109	0.00135	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00109	0.00135	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00107	0.00133	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00107	0.00132	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00104	0.00129	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00103	0.00128	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00101	0.00125	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.001	0.00124	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM4—Parkinson's disease	0.001	0.00124	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000997	0.00124	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TAC1—Parkinson's disease	0.000992	0.00123	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000989	0.00123	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD1—Parkinson's disease	0.000973	0.00121	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.00097	0.0012	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000969	0.0012	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000966	0.0012	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PENK—Parkinson's disease	0.000949	0.00118	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAG—Parkinson's disease	0.000949	0.00118	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000946	0.00117	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000946	0.00117	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD3—Parkinson's disease	0.000942	0.00117	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000939	0.00116	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000938	0.00116	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000938	0.00116	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000935	0.00116	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000935	0.00116	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00088	0.00109	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000877	0.00109	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PDYN—Parkinson's disease	0.000868	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000865	0.00107	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD2—Parkinson's disease	0.000852	0.00106	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR7—Parkinson's disease	0.000852	0.00106	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000849	0.00105	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000849	0.00105	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GFAP—Parkinson's disease	0.000816	0.00101	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000813	0.00101	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GRM5—Parkinson's disease	0.000807	0.000999	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000804	0.000996	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000753	0.000933	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000751	0.000931	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000749	0.000928	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000716	0.000887	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000713	0.000884	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGF20—Parkinson's disease	0.000707	0.000876	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000705	0.000873	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000686	0.00085	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000684	0.000847	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—EDN1—Parkinson's disease	0.000682	0.000845	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.00068	0.000843	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000657	0.000814	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000655	0.000812	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INSR—Parkinson's disease	0.000633	0.000784	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000631	0.000782	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—FGB—Parkinson's disease	0.000598	0.000741	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000597	0.000739	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000596	0.000739	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	0.000595	0.000737	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000595	0.000737	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000593	0.000735	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TAC1—Parkinson's disease	0.000586	0.000726	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000584	0.000724	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD1—Parkinson's disease	0.000575	0.000712	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000573	0.00071	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD3—Parkinson's disease	0.000557	0.00069	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000555	0.000687	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	0.00052	0.000644	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000518	0.000642	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR7—Parkinson's disease	0.000503	0.000624	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD2—Parkinson's disease	0.000503	0.000624	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000502	0.000622	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000502	0.000622	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF2—Parkinson's disease	0.000422	0.000523	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.00042	0.000521	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	0.000408	0.000505	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000407	0.000504	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—EDN1—Parkinson's disease	0.000403	0.000499	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000402	0.000498	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NGF—Parkinson's disease	0.00037	0.000459	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000369	0.000457	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	0.000353	0.000437	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000351	0.000435	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—APOE—Parkinson's disease	0.000328	0.000406	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000327	0.000405	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INS—Parkinson's disease	0.00028	0.000347	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000279	0.000346	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—CASP3—Parkinson's disease	0.000208	0.000258	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000208	0.000257	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—IL6—Parkinson's disease	0.000207	0.000257	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000206	0.000256	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	0.000192	0.000237	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000191	0.000237	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—IL6—Parkinson's disease	0.000122	0.000152	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—IL6—Parkinson's disease	0.000122	0.000151	CbGpPWpGaD
